<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-marinedrugs-17-00357" class="ref">
 <label class="label">29.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Cian</surname>
    <given-names class="given-names">R.E.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hernández-Chirlaque</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Gámez-Belmonte</surname>
    <given-names class="given-names">R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Drago</surname>
    <given-names class="given-names">S.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sánchez de Medina</surname>
    <given-names class="given-names">F.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Martínez-Augustin</surname>
    <given-names class="given-names">O.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Green alga 
   <italic class="italic">Ulva</italic> sp. hydrolysates and their peptide fractions regulate cytokine production in splenic macrophages and lymphocytes involving the TLR4-NFκB/MAPK pathways
  </article-title>
  <source class="source">Mar. Drugs</source>
  <year class="year">2018</year>
  <volume class="volume">16</volume>
  <elocation-id class="elocation-id">235</elocation-id>
  <pub-id pub-id-type="doi" class="pub-id">10.3390/md16070235</pub-id>
  <?supplied-pmid 29997311?>
  <pub-id pub-id-type="pmid" class="pub-id">29997311</pub-id>
 </element-citation>
</ref>
